237 related articles for article (PubMed ID: 23397052)
1. Impaired cliff avoidance reaction in dopamine transporter knockout mice.
Yamashita M; Sakakibara Y; Hall FS; Numachi Y; Yoshida S; Kobayashi H; Uchiumi O; Uhl GR; Kasahara Y; Sora I
Psychopharmacology (Berl); 2013 Jun; 227(4):741-9. PubMed ID: 23397052
[TBL] [Abstract][Full Text] [Related]
2. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
Yamashita M; Fukushima S; Shen HW; Hall FS; Uhl GR; Numachi Y; Kobayashi H; Sora I
Neuropsychopharmacology; 2006 Oct; 31(10):2132-9. PubMed ID: 16407898
[TBL] [Abstract][Full Text] [Related]
3. Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice.
Arime Y; Kasahara Y; Hall FS; Uhl GR; Sora I
Neuropsychopharmacology; 2012 Oct; 37(11):2522-30. PubMed ID: 22781838
[TBL] [Abstract][Full Text] [Related]
4. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
Perona MT; Waters S; Hall FS; Sora I; Lesch KP; Murphy DL; Caron M; Uhl GR
Behav Pharmacol; 2008 Sep; 19(5-6):566-74. PubMed ID: 18690111
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of dopamine transporter knockout mice as an animal model of AD/HD].
Kasahara Y; Kubo Y; Sora I
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):185-9. PubMed ID: 25069256
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.
Uchiumi O; Kasahara Y; Fukui A; Hall FS; Uhl GR; Sora I
Neuropharmacology; 2013 Jan; 64():348-56. PubMed ID: 22809709
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.
Mereu M; Contarini G; Buonaguro EF; Latte G; Managò F; Iasevoli F; de Bartolomeis A; Papaleo F
Neuropharmacology; 2017 Jul; 121():179-194. PubMed ID: 28454982
[TBL] [Abstract][Full Text] [Related]
8. Novelty-related behavior of young and adult dopamine transporter knockout rats: Implication for cognitive and emotional phenotypic patterns.
Adinolfi A; Carbone C; Leo D; Gainetdinov RR; Laviola G; Adriani W
Genes Brain Behav; 2018 Apr; 17(4):e12463. PubMed ID: 29406596
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice.
Fox MA; Panessiti MG; Hall FS; Uhl GR; Murphy DL
Psychopharmacology (Berl); 2013 Jun; 227(4):685-95. PubMed ID: 23417514
[TBL] [Abstract][Full Text] [Related]
10. Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.
Wakabayashi C; Numakawa T; Ooshima Y; Hattori K; Kunugi H
Psychopharmacology (Berl); 2015 Dec; 232(24):4393-400. PubMed ID: 26359228
[TBL] [Abstract][Full Text] [Related]
11. Effects of Atomoxetine on Motor and Cognitive Behaviors and Brain Electrophysiological Activity of Dopamine Transporter Knockout Rats.
Ptukha M; Fesenko Z; Belskaya A; Gromova A; Pelevin A; Kurzina N; Gainetdinov RR; Volnova A
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291693
[TBL] [Abstract][Full Text] [Related]
12. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
Del'Guidice T; Lemasson M; Etiévant A; Manta S; Magno LA; Escoffier G; Roman FS; Beaulieu JM
Psychopharmacology (Berl); 2014 Jan; 231(1):109-22. PubMed ID: 23912772
[TBL] [Abstract][Full Text] [Related]
13. A new "sudden fright paradigm" to explore the role of (epi)genetic modulations of the DAT gene in fear-induced avoidance behavior.
Zelli S; Brancato A; Mattioli F; Pepe M; Alleva E; Carbone C; Cannizzaro C; Adriani W
Genes Brain Behav; 2021 Apr; 20(4):e12709. PubMed ID: 33070435
[TBL] [Abstract][Full Text] [Related]
14. Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats.
Leo D; Sukhanov I; Zoratto F; Illiano P; Caffino L; Sanna F; Messa G; Emanuele M; Esposito A; Dorofeikova M; Budygin EA; Mus L; Efimova EV; Niello M; Espinoza S; Sotnikova TD; Hoener MC; Laviola G; Fumagalli F; Adriani W; Gainetdinov RR
J Neurosci; 2018 Feb; 38(8):1959-1972. PubMed ID: 29348190
[TBL] [Abstract][Full Text] [Related]
15. Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.
Takamatsu Y; Hagino Y; Sato A; Takahashi T; Nagasawa SY; Kubo Y; Mizuguchi M; Uhl GR; Sora I; Ikeda K
Curr Mol Med; 2015; 15(3):245-52. PubMed ID: 25817856
[TBL] [Abstract][Full Text] [Related]
16. Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
Hall FS; Sora I; Hen R; Uhl GR
PLoS One; 2014; 9(12):e115009. PubMed ID: 25514162
[TBL] [Abstract][Full Text] [Related]
17. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.
Woo H; Park SJ; Lee Y; Kwon G; Gao Q; Lee HE; Ahn YJ; Shin CY; Cheong JH; Ryu JH
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():206-15. PubMed ID: 24953433
[TBL] [Abstract][Full Text] [Related]
18. Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.
Mannangatti P; Ragu Varman D; Ramamoorthy S; Jayanthi LD
Pharmacology; 2021; 106(11-12):597-605. PubMed ID: 34515205
[TBL] [Abstract][Full Text] [Related]
19. Reward-enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention-deficit/hyperactivity disorder.
Ide S; Ikekubo Y; Hua J; Takamatsu Y; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacol Rep; 2018 Sep; 38(3):149-153. PubMed ID: 30175528
[TBL] [Abstract][Full Text] [Related]
20. Noise benefit in prepulse inhibition of the acoustic startle reflex.
Pålsson E; Söderlund G; Klamer D; Bergquist F
Psychopharmacology (Berl); 2011 Apr; 214(3):675-85. PubMed ID: 21107541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
